BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28858970)

  • 21. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Green H; Jones AM
    Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis.
    Murray TS; Stanley G; Koff JL
    Infect Dis Clin North Am; 2024 Mar; 38(1):149-162. PubMed ID: 38280761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
    Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
    Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
    Dobbin C; Maley M; Harkness J; Benn R; Malouf M; Glanville A; Bye P
    J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of lung transplantation for cystic fibrosis--Danish results.
    Bech B; Pressler T; Iversen M; Carlsen J; Milman N; Eliasen K; Perko M; Arendrup H
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1180-6. PubMed ID: 15541981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organ Transplantation for Cystic Fibrosis.
    Morrell MR; Kiel SC; Pilewski JM
    Semin Respir Crit Care Med; 2019 Dec; 40(6):842-856. PubMed ID: 31887769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful lung transplant in a child with cystic fibrosis and persistent Blastobotrys rhaffinosifermentans infection.
    Wong JY; Chambers AL; Fuller J; Lacson A; Mullen J; Lien D; Humar A
    Pediatr Transplant; 2014 Aug; 18(5):E169-73. PubMed ID: 24930454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which pathogens should we worry about?
    Jones AM
    Paediatr Respir Rev; 2019 Aug; 31():15-17. PubMed ID: 30967346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.
    Waters V; Ratjen F
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):807-19. PubMed ID: 17140357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung transplantation for non-cystic fibrosis bronchiectasis.
    Rademacher J; Ringshausen FC; Suhling H; Fuge J; Marsch G; Warnecke G; Haverich A; Welte T; Gottlieb J
    Respir Med; 2016 Jun; 115():60-5. PubMed ID: 27215505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis.
    Moore JE; Mastoridis P
    J Clin Pharm Ther; 2017 Jun; 42(3):259-267. PubMed ID: 28374433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of burkholderia infection on lung transplantation in cystic fibrosis.
    Murray S; Charbeneau J; Marshall BC; LiPuma JJ
    Am J Respir Crit Care Med; 2008 Aug; 178(4):363-71. PubMed ID: 18535253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung Transplantation for Cystic Fibrosis.
    Morrell MR; Pilewski JM
    Clin Chest Med; 2016 Mar; 37(1):127-38. PubMed ID: 26857774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis lung transplantation.
    Braun AT; Merlo CA
    Curr Opin Pulm Med; 2011 Nov; 17(6):467-72. PubMed ID: 21897255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population.
    Qvist T; Pressler T; Thomsen VO; Skov M; Iversen M; Katzenstein TL
    Transplant Proc; 2013; 45(1):342-5. PubMed ID: 23267788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients.
    Vital D; Hofer M; Benden C; Holzmann D; Boehler A
    Respiration; 2013; 86(1):25-31. PubMed ID: 22922656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic fibrosis physicians' perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States.
    Ramos KJ; Somayaji R; Lease ED; Goss CH; Aitken ML
    BMC Pulm Med; 2017 Jan; 17(1):21. PubMed ID: 28103851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.